13 Oct Biosketch 101: Getting (Grant Reviewers) to Know You
The biographical sketch (or “biosketch”) is where you get to show grant reviewers what you—as PI or other key personnel—will bring to a proposed project. In this session, we will discuss how to make your experience and expertise shine through in the Personal Statement and Contributions to Science sections of the biosketch. We will also cover key changes the NIH biosketch format that take effect in 2022 so that you can make sure yours complies with the latest NIH policy.
To make the most of this session, have a copy of your current biosketch handy. The session will include breakout sessions to workshop the narrative sections.
You should also pre-read the new NIH Biosketch Instructions (for grants with due dates on/after Jan 25, 2022).
At the end of the session, attendees will be able to:
- Understand the different biosketch formats and when to use them
- (Re)format their biosketch to meet new requirements that will be enforced starting January 25, 2022
- List two tactics for demonstrating experience in the Personal Statement
Schedule of Activities
- 12:00-12:05pm – Welcome/Introduction
- 12:05-1:25pm – Presentation and Discussion
- 1:25-1:30pm – Thank You/Closing
About the Speakers
Melissa Vaught, PhD, is the Director of Research Development for ITHS, facilitating proposal development for strategic initiatives across ITHS. She also provides personalized guidance to ITHS resources for investigators, fellows, and students conducting clinical and translational research. Dr. Vaught earned her PhD in Chemistry at Vanderbilt University and continued research at the interface of biology and chemistry as a postdoctoral fellow in Boston, MA. As a contractor at the National Center for Biotechnology Information (NCBI) for almost four years, she managed daily operations of post-publication projects. She joined ITHS in 2018 as the Research Navigator and has served as Director of Research Development since December 2019.
Alysia vandenBerg, PhD, is the Grants Development Manager for ITHS. Dr. vandenBerg has a PhD in Cellular and Molecular biology from the University of Vermont. Her postdoctoral studies took her from New York to Paris, France, where she studied cellular signaling processes involved in cancers of the female reproductive tract. Before joining ITHS in 2020, she worked at Fred Hutch as program manager for a range of efforts that spurred research in strategic areas. She has a dozen years’ experience in grant development, program management, and scientific communications on two continents.